ARS:年度报告
04/26 06:18 (美东)
DEFA14A:其他
04/26 06:13 (美东)
DEF 14A:股东委托书决议
04/26 06:13 (美东)
PRE 14A:并购重组委托声明
04/16 08:05 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 424B3:募资说明书
04/04 08:45 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 8-K:重大事件
04/04 08:40 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 424B5:募资说明书
04/04 08:20 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | EFFECT:其他
04/03 06:07 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | POS AM:修改注册声明表
03/29 14:57 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | S-8:员工福利计划证券登记
03/28 16:07 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 10-K:年度报表
03/26 08:59 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 8-K:Effector Therapeutics公布2023年第四季度和全年财务业绩并提供公司最新情况
03/25 16:15 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-董事 Loewy Caroline M
02/21 17:42 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-董事 Bhatt Elizabeth
02/21 17:33 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-董事 Ehrlich Christopher B
02/21 17:32 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-董事 Klencke Barbara
02/21 17:28 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-董事 Harrington-Smith Kristen
02/21 17:26 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-董事 Gallagher Brian M. Jr.
02/21 17:24 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-高管 Byrnes Michael
02/21 17:09 (美东)
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4:持股变动声明-高管 Warner Douglas J
02/21 17:07 (美东)
暂无数据
暂无数据